The standard measure of lesion count may matter less than the underlying biology driving treatment response in ...

The study, “The Role of Utilizing Community Oncology Care To Decrease Cancer-Related Financial Toxicity,” 1 analyzes ...

Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that clinical data from ...

Working among friends is a privilege. Recruiting one’s friends makes it easier. This is the story of how one Vail Health ...

Azacitidine and decitabine belong to a class of antineoplastic agents known as DNA methyltransferase inhibitors (DMTIs). Each is paired with cedazuridine, a cytidine deaminase inhibitor, to help the ...

Mural Oncology plc, (Nasdaq: MURA) (“Mural”) announces that the scheme of arrangement between Mural and its shareholders under Chapter 1 of Part 9 of the Companies Act 2014 (the “Scheme”) pursuant to ...

Mural Oncology plc, (Nasdaq: MURA) ("Mural") announces that the scheme of arrangement between Mural and its shareholders under Chapter 1 of ...

Popular weight-loss drugs “probably have little or no effect” on a person’s risk of developing one of the 13 obesity-related ...

When we think about cancer, most people picture dramatic symptoms — sudden weight loss, deep tiredness, perhaps a ...

The IDEXX Cancer Dx is a new blood-based screening/diagnostic panel aimed at detecting canine lymphoma from serum or whole ...

Explore how advancements in robotic surgery and radiation therapy are revolutionizing cancer care with precision and improved ...

A new clinical trial suggests that pairing bispecific antibodies and antibody-drug conjugates with CAR T-cell therapy may ...